U.S. Trade Representative Katherine Tai on Wednesday met virtually with the top executive of drugmaker Moderna to discuss a proposed waiver of certain intellectual property rights in response to the COVID-19 pandemic, Tai's office said.
Tai and Moderna Chief Executive Stephane Bancel also discussed increasing vaccine production and global health issues, Tai's office said in a statement.
https://finance.yahoo.com/news/u-trade-negotiator-discusses-covid-003000435.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.